NDAINHALATIONGAS
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
NITROGEN, NF (nitrogen) by Advanced Solutions Life Sciences. Approved for critical illness, postoperative complications, nutrition therapy and 6 more indications. First approved in 2013.
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NITROGEN, NF is a pharmaceutical-grade nitrogen gas delivered via inhalation for clinical use across diverse indications including critical illness, postoperative complications, nutrition therapy, and various malignancies. The product functions as a medical gas with no defined mechanism of action in traditional pharmacological terms. It is indicated for critical care, nutritional support, and treatment of conditions ranging from hepatitis C to superficial basal cell carcinoma.
Peak
Product is in peak lifecycle stage with no publicly reported spending data, suggesting a niche market with limited commercial team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.